VEGF Human, Baculovirus
目录号 : GP21039Vascular Endothelial Growth Factor Human Recombinant, Baculovirus
Sample solution is provided at 25 µL, 10mM.
Purity | Greaterthan 85.0% as determined by SDS-PAGE. | Source | Sf9,Baculovirus cells. |
Phycical Appearance | Sterilefiltered colorless solution. | Shipping Condition | Shipped with Ice Packs. |
Synonyms | Vascular Endothelial Growth Factor A; VEGF; Vascular PermeabilityFactor; MVCD1; VPF; Vascular Endothelial Growth Factor; VEGF-A; Vascularendothelial growth factor A. | ||
Amino Acid Sequence | MNFLLSWVHW SLALLLYLHH AKWSQAAPMA EGGGQNHHEV VKFMDVYQRSYCHPIETLVD IFQEYPDEIE YIFKPSCVPL MRCGGCCNDE GLECVPTEES NITMQIMRIK PHQGQHIGEMSFLQHNKCEC RPKKDRARQE NPCGPCSERR KHLFVQDPQT CKCSCKNTDS RCKARQLELNERTCRCDKPR RHHHHHH. | ||
Stability | Store at 4°C if entire vial will be used within 2-4weeks.Store, frozen at -20°C for longer periods of time.For long term storage it is recommended to add a carrierprotein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. | ||
Formulation | VEGF protein solution (0.25mg/ml) contains Phosphatebuffered saline (pH7.4), 10% glycerol, 1mM DTT and 0.1mM PMSF. |
Vascular endothelial growth factor is an important signaling protein involved in both vasculogenesis and angiogenesis. As its name implies, VEGF activity has been mostly studied on cells of the vascular endothelium, although it does have effects on a number of other cell types (e.g. stimulation monocyte/ macrophagemigration, neurons, cancer cells, kidney epithelial cells ).VEGF mediates increased vascular permeability, induces angiogenesis, vasculogenesis and endothelial cell growth, promotes cell migration, and inhibits apoptosis. In vitro, VEGF has been shown to stimulate endothelial cell mitogenesisand cell migration. VEGF is also a vasodilator and increases microvascular permeability and was originally referred to as vascular permeability factor.Elevated levels of this protein are linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy.
Store at 4°C if entire vial will be used within 2-4weeks.Store, frozen at -20°C for longer periods of time.For long term storage it is recommended to add a carrierprotein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.